In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Crinex Brand of Amfepramone Hydrochloride Drug Master File in Korea (Crinex Brand of Amfepramone Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Crinex Brand of Amfepramone Hydrochloride. The MFDS reviews the Crinex Brand of Amfepramone Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Crinex Brand of Amfepramone Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Crinex Brand of Amfepramone Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Crinex Brand of Amfepramone Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Crinex Brand of Amfepramone Hydrochloride suppliers with KDMF on PharmaCompass.